Literature DB >> 17639167

Characteristics of Chlamydia trachomatis infection in hospitalized infants with lower respiratory tract infection.

Chun Jen Chen1, Keh Gong Wu, Ren Bin Tang, Han Chih Yuan, Wen Jue Soong, Be Tau Hwang.   

Abstract

BACKGROUND AND
PURPOSE: To study the epidemiology, presentation and laboratory findings of Chlamydia trachomatis pneumonia in hospitalized infants younger than 6 months.
METHODS: Between January 2001 and December 2005, infants younger than 6 months admitted to the children's medical center of Taipei Veterans General Hospital with the diagnosis of acute bronchiolitis, bronchopneumonia or pneumonia were prospectively studied. Chest radiograph findings were reviewed in all patients. Basic laboratory examinations performed included white blood cell count and eosinophil count. C. trachomatis was detected via enzyme-linked immunosorbent assay antigen test and the titers of immunoglobulin G and immunoglobulin M by indirect immunoperoxidase assay.
RESULTS: A total of 60 infants, 32 males and 28 females, were included. C. trachomatis infection was detected in 30% of patients (18/60). The median age was 2.5 months (range, birth to 6 months). Fever was not detected in 72% of patients (13/18). Only 22% (4/18) of these patients had the characteristic staccato cough. The mean duration of symptoms before admission was 8 days (range, 1 day to 2 months). Rhinorrhea was a prodromal symptom in 67% (12/18) of patients, with a mean pre-onset duration of 7 days (range, 1 to 14 days). Eighty three percent (15/18) of the patients had tachypnea, with a mean duration of 3.2 days (range, 1 to 7 days). Conjunctivitis was noted before admission in 6 patients (33%). Only peripheral eosinophils showed statistically significant difference between Chlamydia-positive and -negative disease (p=0.046), and may be clinically useful in cases of suspected C. trachomatis infection. Mixed infection with other pathogens including adenovirus, respiratory syncytial virus, Mycoplasma pneumoniae, cytomegalovirus and Streptococcus pneumoniae was found in 27% (5/18) of patients.
CONCLUSIONS: C. trachomatis is not infrequent and plays an important role in infants younger than 6 months old hospitalized due to lower respiratory tract infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639167

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  6 in total

1.  Influence of different delivery modes on the clinical characteristics of Chlamydia trachomatis pneumonia.

Authors:  Jiejing Xu; Lili Yu; Baidi Fu; Deyu Zhao; Feng Liu
Journal:  Eur J Pediatr       Date:  2018-05-31       Impact factor: 3.183

2.  Not every cough in bronchiolitis season is bronchiolitis.

Authors:  Ronelle Vanessa Naidoo; Penelope Ann Bryant
Journal:  BMJ Case Rep       Date:  2009-08-28

3.  Chlamydia trachomatis growth inhibition and restoration of LDL-receptor level in HepG2 cells treated with mevastatin.

Authors:  Yuriy K Bashmakov; Nailya A Zigangirova; Yulia P Pashko; Lidia N Kapotina; Ivan M Petyaev
Journal:  Comp Hepatol       Date:  2010-01-28

4.  Detection of Chlamydia trachomatis infections by polymerase chain reaction in asymptomatic pregnant women with special reference to the utility of the pooling of urine specimens.

Authors:  Sunil Sethi; Amit Roy; Shubha Garg; Lakshmi Sree Venkatesan; Rashmi Bagga
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

5.  Detection of C. trachomatis in the serum of the patients with urogenital chlamydiosis.

Authors:  Naylia A Zigangirova; Yulia P Rumyantseva; Elena Y Morgunova; Lidia N Kapotina; Lubov V Didenko; Elena A Kost; Ekaterina A Koroleva; Yuriy K Bashmakov; Ivan M Petyaev
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

6.  Low prevalence of Chlamydia trachomatis infection in non-urban pregnant women in Vellore, S. India.

Authors:  Navjyot K Vidwan; Annie Regi; Mark Steinhoff; Jill S Huppert; Mary Allen Staat; Caitlin Dodd; Rida Nongrum; Shalini Anandan; Valsan Verghese
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.